Biotricity Inc. financial data

Symbol
BTCY on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
203 Redwood Parkway, Suite 600, Redwood City, CA
State of incorporation
Nevada
Fiscal year end
March 31
Former names
METASOLUTIONS, INC. (to 1/5/2016)
Latest financial report
10-Q - Q2 2024 - Aug 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 22.2 % -59.3%
Quick Ratio 10 % -54.5%
Debt-to-equity -115 % +17.3%
Return On Equity 49.7 % -50.2%
Return On Assets -243 % +3.95%
Operating Margin -62.3 % +51.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.5M shares +156%
Common Stock, Shares, Outstanding 21.5M shares -57.9%
Entity Public Float 16.3M USD -49.9%
Common Stock, Value, Issued 21.6K USD -58.8%
Weighted Average Number of Shares Outstanding, Basic 14.2M shares +61.9%
Weighted Average Number of Shares Outstanding, Diluted 14.2M shares +61.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 12.2M USD +15.5%
Cost of Revenue 3.44M USD -23%
Research and Development Expense 2.37M USD -24%
General and Administrative Expense 20.5M USD +17.9%
Operating Income (Loss) -7.63M USD +44.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.4M USD +16.9%
Net Income (Loss) Attributable to Parent -14.4M USD +16.9%
Earnings Per Share, Basic -1.74 USD/shares +32%
Earnings Per Share, Diluted -1.74 USD/shares +32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 101K USD +95.8%
Accounts Receivable, after Allowance for Credit Loss, Current 1.52M USD +0.34%
Inventory, Net 1.91M USD -13.6%
Assets, Current 4.09M USD -6.97%
Property, Plant and Equipment, Net 14.1K USD -29.7%
Operating Lease, Right-of-Use Asset 1.12M USD -25.1%
Assets 5.42M USD -11.8%
Accrued Liabilities, Current 3.2M USD +33.9%
Liabilities, Current 20.6M USD +36.3%
Operating Lease, Liability, Noncurrent 803K USD -37.2%
Liabilities 33M USD +11.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 56K USD
Retained Earnings (Accumulated Deficit) -134M USD -15.7%
Stockholders' Equity Attributable to Parent -29.8M USD -27.2%
Liabilities and Equity 5.42M USD -11.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.49M USD +18.4%
Net Cash Provided by (Used in) Financing Activities 868K USD -34.7%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 21.5M shares -57.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.86M USD -143%
Interest Paid, Excluding Capitalized Interest, Operating Activities 707K USD +173%
Deferred Tax Assets, Valuation Allowance 18.2M USD +18.1%
Operating Lease, Liability 1.28M USD -21.5%
Depreciation 5.95K USD -0.02%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.9M USD +0.07%
Lessee, Operating Lease, Liability, to be Paid 1.72M USD -12.8%
Property, Plant and Equipment, Gross 29.8K USD 0%
Operating Lease, Liability, Current 475K USD +35.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 565K USD -5.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 600K USD +8.69%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 440K USD +28.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 565K USD -5.82%
Preferred Stock, Shares Issued 1 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 565K USD
Additional Paid in Capital 104M USD +12.1%
Preferred Stock, Shares Outstanding 1 shares 0%
Interest Expense 3.13M USD +48.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%